tirzepatide anesthesia Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: Society for Perioperative Assessment and Quality Improvement (SPAQI) multidisciplinary consensus statement What to Tell Your Anesthesiologist

Weight loss momentum typically resumes once regular dosing is reestablished, though the interruption does represent lost time toward achieving target weight goals

doi:10.1097/00005176-198601000-00008

Clinical trials have shown that semaglutide and liraglutide are generally well tolerated, with gastrointestinal disorders being the most commonly reported AEs, including nausea, diarrhea, vomiting, and constipation, leading to dose reduction or temporary treatment interruption in 12.5% of study participants [40,41,42]

A single agonist engages only the GLP-1 receptor

Psyllium Husk Powder // Naturally sourced, hand selected husk, delicately milled to perfection